VEGF inhibition beyond tumour progression

Axel Grothey

doi:10.1016/S1470-2045(12)70516-8

VEGF inhibition beyond tumour progression

Axel Grothey

Medical Oncology

Research output: Contribution to journal › Letter › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	2-3
Number of pages	2
Journal	The Lancet Oncology
Volume	14
Issue number	1
DOIs	https://doi.org/10.1016/S1470-2045(12)70516-8
State	Published - Jan 2013

ASJC Scopus subject areas

Oncology

Access to Document

10.1016/S1470-2045(12)70516-8

Cite this

@article{bf004b2b02114a8d8b12ab45e1006433,

title = "VEGF inhibition beyond tumour progression",

author = "Axel Grothey",

year = "2013",

month = jan,

doi = "10.1016/S1470-2045(12)70516-8",

language = "English (US)",

volume = "14",

pages = "2--3",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "1",

}

TY - JOUR

T1 - VEGF inhibition beyond tumour progression

AU - Grothey, Axel

PY - 2013/1

Y1 - 2013/1

UR - http://www.scopus.com/inward/record.url?scp=84871714636&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871714636&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(12)70516-8

DO - 10.1016/S1470-2045(12)70516-8

M3 - Letter

C2 - 23168363

AN - SCOPUS:84871714636

SN - 1470-2045

VL - 14

SP - 2

EP - 3

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 1

ER -

VEGF inhibition beyond tumour progression

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this